CLPBH - SPRED HOUSE DURA-SATIN FINISH 2906

  • MSDS: CLPBH
  • Manufacturer: GLIDDEN PAINT ICI PAINTS
  • Product Name: SPRED HOUSE DURA-SATIN FINISH 2906
  • National Stock Number: -
Product Identification

Product ID:SPRED HOUSE DURA-SATIN FINISH 2906
MSDS Date:06/01/1992
FSC:NIIN:Submitter:F BT
Status Code:A
MSDS Number: CLPBH

Responsible Party
GLIDDEN PAINT, ICI PAINTS
925 EUCLID AVE
CLEVELAND, OH 44115
US

Emergency Phone: 800-545-2643

Info Phone: 800-545-2643/216-344-8207

Cage: 01PD6

Contractor
GLIDDEN PAINT, ICI PAINTS NORTH AMERICA
CLEVELAND, OH 44115 US

Telephone: 800-545-2643/216-344-8207

Cage: 01PD6

Ingredients

1,2-ETHANEDIOL

CAS: 107-21-1

RTECS: KW2975000

ACGIH TLV: C 50 PPM

EPA Report Quantity: 1 LB

DOT Report Quantity: 1 LB


QUARTZ

CAS: 14808-60-7

RTECS: VV7330000

OSHA PEL 0.1 MG/M3

ACGIH TLV: 0.1 MG/M3


PROPANOIC ACID, 2-METHYL-, MONOESTER WITH

CAS: 25265-77-4

RTECS: UF6000000


TITANIUM OXIDE

CAS: 13463-67-7

RTECS: XR2275000

OSHA PEL 10 MG/M3

ACGIH TLV: 10 MG/M3


ACRYLIC COPOLYMER


WATER

CAS: 7732-18-5

RTECS: ZC0110000

Hazards

Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:NO IARC:YES OSHA:NO
Health Hazards Acute and Chronic:ORAL CONSUMPTION OF PRODUCTS
CONTAINING ETHYLENE GLYCOL MAY PRODUCE ADVERSE HEALTH EFFECTS.
INGESTION OF LARGE VOLUMES OF ETHYLENE GLYCOL MAY RESULT IN KIDNEY
DAMAGE AND/OR FAILURE.
Explanation of Carcinogenicity:IARC HAS DETERMINED THAT THERE IS
SUFFICIENT EVIDENCE FOR THE CARCINOGENICITY OF CRYSTALLINE SILICA
TO EXPERIMENTAL ANIMALS, AND LIMITED EVIDENCE FOR THE
CARCINOGENICITY OF CRYSTALLINE SILICA TO HUMAN S.
Effects of Overexposure:INHALATION: IRRITATION OF RESPIRATORY TRACT.
PROLONGED INHALATION MAY LEAD TO MUCOUS MEMBRANE IRRITATION,
DROWSINESS, DIZZINESS AND/OR LIGHTHEADEDNESS. SKIN: IRRITATION OF
SKIN. MAY RESULT IN DERMA L ABSORPTION OF COMPONENTS OF THIS
PRODUCT WHICH MAY CAUSE GASTRO-INTESTINAL DISTURBANCES, APATHY.
EYE: IRRITATION OF EYES. INGESTION: MAY CAUSE DROWSINESS,
DIZZINESS, AND/OR LIGHTHEADEDNESS, HEADACHE , NAUSEA, VOMITING,
DIARRHEA, GASTRO-INTESTINAL DISTURBANCES.
Medical Cond Aggravated by Exposure:INGREDIENTS CONTAINED IN THESE
PRODUCTS HAVE BEEN REPORTED TO AGGRAVATE PREEXISTING EYE, SKIN,
RESPIRATORY, LUNG AND KIDNEY DISORDERS.

First Aid

First Aid:INHALATION: REMOVE TO FRESH AIR. RESTORE AND SUPPORT
BREATHING. HAVE TRAINED PERSON GIVE OXYGEN IF NECESSARY. SKIN:
WASH OFF QUICKLY WITH PLENTY OF WATER, THEN SOAP AND WATER; REMOVE
CONTAMINATED C LOTHING. WASH CONTAMINATED CLOTHING BEFORE REUSE.
EYE: FLUSH IMMEDIATELY WITH LARGE AMOUNTS OF WATER, ESPECIALLY
UNDER LIDS, FOR AT LEAST 15 MINUTES. INGESTION: IF SWALLOWED,
OBTAIN MEDICAL TREATMEN T IMMEDIATELY! IN ALL CASES, SEEK
IMMEDIATE MEDICAL ATTENTION!

Fire Fighting

Flash Point:NONE
Extinguishing Media:DRY CHEMICAL OR FOAM.
Fire Fighting Procedures:WATER MAY BE USED TO COOL AND PROTECT EXPOSED
CONTAINERS.
Unusual Fire/Explosion Hazard:CLOSED CONTAINERS MAY EXPLODE WHEN
EXPOSED TO EXTREME HEAT OR FIRE.

Accidental Release

Spill Release Procedures:COMPLY WITH ALL APPLICABLE HEALTH AND
ENVIRONMENTAL REGULATIONS. VENTILATE AREA. SPILLS MAY BE COLLECTED
WITH ABSORBENT MATERIALS.

Handling

Handling and Storage Precautions:STORE BELOW 100 F. KEEP FROM
FREEZING. KEEP AWAY FROM HEAT, SPARKS AND OPEN FLAME.
Other Precautions:USE ONLY WITH ADEQUATE VENTILATION. DO NOT TAKE
INTERNALLY. KEEP OUT OF REACH OF CHILDREN. AVOID CONTACT WITH SKIN
AND EYES, AND BREATHING OF VAPORS. WASH HANDS THOROUGHLY AFTER
HANDLING, ESPECIALLY B EFORE EATING OR SMOKING. KEEP CONTAINERS
TIGHTLY CLOSED AND UPRIGHT WHEN NOT IN USE.

Exposure Controls

Respiratory Protection:CONTROL ENVIRONMENTAL CONCENTRATIONS BELOW
APPLICABLE STANDARDS. WHERE RESPIRATORY PROTECTION IS REQUIRED,
USE ONLY NIOSH/MSHA APPROVED RESPIRATORS IN ACCORDANCE WITH OSHA
STANDARD 29 CFR 1910.134.
Ventilation:PROVIDE DILUTION VENTILATION OR LOCAL EXHAUST TO PREVENT
BUILD-UP OF VAPORS. USE EXPLOSION-PROOF EQUIPMENT.
Protective Gloves:IMPERVIOUS GLOVES
Eye Protection:SAFETY GLASSES OR GOGGLES
Other Protective Equipment:EYE WASH, SAFETY SHOWER
Supplemental Safety and Health
WT/GAL: 10.0

Chemical Properties

Boiling Pt:B.P. Text:212-477 F
Percent Volatiles by Volume:67.9

Stability

Stability Indicator/Materials to Avoid:YES
OXIDIZERS, HYDROFLUORIC ACID.
Stability Condition to Avoid:ELEVATED TEMPERATURES, CONTACT WITH
OXIDIZING AGENT.
Hazardous Decomposition Products:CARBON MONOXIDE, CARBON DIOXIDE.

Disposal

Waste Disposal Methods:DISPOSE IN ACCORDANCE WITH ALL APPLICABLE
REGULATIONS. AVOID DISCHARGE TO NATURAL WATERS.

Toxicology

Toxicological Information:CRYSTALLINE SILICA IS ALSO A KNOWN CAUSE OF
SILICOSIS, A NONCANCEROUS LUNG DISEASE. STUDIES WITH LABORATORY
ANIMALS SHOW THAT HIGH DOSES OF ETHYLENE GLYCOL, ADMINISTERED
ORALLY, PRODUCE BIRTH DEFECTS IN RATS AND MICE. THERE IS,
HOWEVER, NO CURRENTLY AVAILABLE INFORMATION TO SUGGEST THAT
ETHYLENE GLYCOL HAS CAUSED BIRTH DEFECTS IN HUMANS.

Other Information

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.

Transport

Transport Information:DOT PROPER SHIPPING NAME: PAINT

Regulatory

SARA Title III Information:SARA 313: ETHYLENE GLYCOL